Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Novo Nordisk A/S
Indications and Usage Saxenda (liraglutide [rDNA origin] injection) is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or greater (obese) or 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Serving Minneapolis, St
Studies have shown that short-chain fatty acids (SCFAs) can enhance the expression of tight junction proteins in brain microvascular endothelial cells, thereby reducing barrier permeability (194)
Wegovy and Zepbound are specifically positioned for weight management in combination with reduced-calorie nutrition and increased physical activity
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
